Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics source : Ir.hoththerapeutics.com save search
Hoth Therapeutics Announces Partnership with Altasciences for Manufacturing HT-TBI for Traumatic Brain Injury and Stroke
Published: 2022-09-20 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 0.0%
H: 2.12%
C: -2.77%
partnership stroke therapeutics train
Hoth Therapeutics mRNA Frame-Shifting Therapeutic, HT-004, Shows Potential to Reduce Lung Inflammation in Asthma and Allergy Disorders
Published: 2022-09-06 (Crawled : 12:20) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -2.21%
H: 2.38%
C: -2.14%
ht-004 lung mrna therapeutics potential
Hoth Therapeutics Announces Pipeline Presentation at the 2022 Sidoti Investor Conference
Published: 2022-08-12 (Crawled : 18:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 1.25%
H: 0.0%
C: -1.61%
conference therapeutics presentation
Hoth Therapeutics Granted 180 Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
Published: 2022-06-29 (Crawled : 18:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 0.58%
H: 8.04%
C: 3.15%
day nasdaq extension granted therapeutics
Hoth Therapeutics Announces Extension of Washington University Alzheimer's Mouse Model Study with Alzheimer's Therapeutic HT-ALZ
Published: 2022-06-09 (Crawled : 12:20) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -1.33%
H: 2.3%
C: -1.14%
alzheimer's therapeutics alzheimer’s ht-alz
Hoth Therapeutics Announces New Pipeline Asset, HT-TBI for Stroke and Traumatic Brain Injury
Published: 2022-04-19 (Crawled : 15:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -1.35%
H: 15.67%
C: 4.13%
stroke therapeutics train
Hoth Therapeutics, Inc. Announces Closing of $7.0 Million Underwritten Public Offering Priced At-The-Market
Published: 2022-04-14 (Crawled : 17:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 1.08%
H: 6.54%
C: 5.02%
offering
Hoth Therapeutics Announces Acceptance to Present HT-ALZ Proof-of-Concept Alzheimer's Disease Data at the 2022 Alzheimer's Association International Conference
Published: 2022-04-12 (Crawled : 12:20) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -23.34%
H: 0.62%
C: -10.55%
conference disease therapeutics international alzheimer's alzheimer’s ht-alz
Hoth Therapeutics Announces Pipeline Presentation at the 2022 BIO International Convention
Published: 2022-04-01 (Crawled : 12:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 1.01%
H: 1.5%
C: -1.26%
therapeutics presentation international
Hoth Therapeutics Announces Orphan Drug Designation Granted to Cancer Therapeutic HT-KIT to Treat Mastocytosis
Published: 2022-03-11 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -6.73%
H: 0.0%
C: 0.0%
drug granted therapeutics drug designation orphan drug cancer grant designation
Hoth Therapeutics Announces Presentation of the HT-ALZ Proof-of-Concept Alzheimer's Disease Preclinical Data at the 2022 Alzheimer's Association International Conference
Published: 2022-02-07 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 5.28%
H: 2.48%
C: -1.32%
alzheimer conference therapeutics presentation disease preclinical roof alzheimer’s alzheimer's disease pre-clinical alzheimer's ht-alz
Hoth Therapeutics Announces the Appointment of John Cirrito, PhD and Carla Yuede, PhD to Oversee Alzheimer's Therapeutic Program as Part of Hoth Scientific Advisory Board
Published: 2022-01-31 (Crawled : 13:30) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 4.58%
H: 6.89%
C: 3.05%
alzheimer program therapeutics alzheimer’s alzheimer's
Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results - Reduce Amyloid β in Alzheimer's Disease
Published: 2022-01-04 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 61.79%
H: 53.51%
C: 14.04%
alzheimer therapeutics disease positive results positive results alzheimer’s alzheimer's disease alzheimer's ht-alz
Hoth Therapeutics Announces Submission of Orphan Drug Designation Request for HT-KIT to Treat Mastocytosis
Published: 2021-12-21 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: -2.64%
drug therapeutics orphan drug submission designation
Hoth Therapeutics Licenses Lupus Therapeutic Back to Zylö Therapeutics
Published: 2021-12-08 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 1.3%
H: 7.49%
C: 3.05%
license therapeutics lupus
Hoth Therapeutics' Enrollment and Dosing in Second Cohort in Phase 1b Human Trial for Atopic Dermatitis Under Way
Published: 2021-11-30 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 0.06%
H: 4.32%
C: -1.8%
atopic dermatitis phase 1 dermatitis phase 1b trial therapeutics enroll phase 2b
Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT
Published: 2021-11-16 (Crawled : 13:30) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -1.95%
H: 0.0%
C: 0.0%
cancer research therapeutics
Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic
Published: 2021-11-08 (Crawled : 13:15) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -0.91%
H: 3.67%
C: 1.83%
cancer contract drug
Hoth Therapeutics Extends Partnership Agreement with REPROCELL
Published: 2021-10-19 (Crawled : 17:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -0.88%
H: 10.71%
C: 0.89%
partnership therapeutics
Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis Patients
Published: 2021-10-12 (Crawled : 14:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 0.0%
H: 12.17%
C: 0.87%
treatment dermatitis trial approval atopic dermatitis xin
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.